Hummer Law Offices: 10333 Seminole Blvd. Suite 14, Largo, Florida 33778. Phone: 727-397-9198
Hummer Law Offices is a licensed Florida attorney for defective medical products in Tampa Bay, Florida. Our law office represents registered claimants in the Settlement For Dow Corning Trust (SFDCT)- DC Settlement - Dow Corning Breast Implants Settlement - Hip Implant Recall - Knee Implant Recall - Merina - Actos - Fosmas & Boniva - Byetta, Januvia, & Janumet - GranFlo - NaturalLyte - Lipitor - Testosterone - Viagra- Xarelto - Yaz, Yasmin and Ocella Litigation Attorneys - Kugel Hernia Mesh Patch - Infusion Pumps - Pain Pumps - Asbestos - GM Ignition Switch Litigation Lawyer In Pinellas County, Florida - Attorney For Social Security Disability In Largo, Seminole, St. Petersburg, Tampa, FL If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, please contact us concerning copyright matters.
The Hummer Law Offices is currently accepting Yaz, Yasmin, Oscella, and Gianvi induced injury cases in all 50 states. If you or somebody you know has been injured by this birth control, you should contact or call our lawyers immediately for a free case consultation at 727-397-9198.
Yasmin, Yaz, Beyaz, Gianvi & Ocella Lawsuit Serious and/or deadly medical complications can include sudden death, heart attack, stroke, pulmonary embolism, blood clots (DMV- deep vein thrombosis), liver tumors, gallbladder disease, depression & more.
The birth control drugs Yaz and Yasmin are the #1 selling oral contraceptives on the US market today, grossing over $391M in the first half of 2009, up 44% from the year before, according to IMS Health, a health data and information provider.
These staggering sales are partly due to the aggressive marketing campaign put forth by Bayer Healthcare Pharmaceuticals, the manufacturer of Yaz ( may also be known by its generic name, Ocella) and Yasmin. The FDA approved Yasmin 2001, and Yaz in 2006.
These fourth generation birth control pills are made of ethinyl estradiol (an estrogen) and the progestin drospirenone, a synthetic progestin hormone. Yaz contains a lower dose of estrogen than Yasmin. Yaz is a form of birth control that prevents ovulation and also works to cause changes in the cervical and uterine lining in a woman's body in order to prevent pregnancy. These changes make it hard for sperm to reach the uterus and they also make it difficult for an egg to become fertilized. This way it cannot become attached to the uterus.
Yaz has been prescribed primarily as a contraceptive medication, however it has also been prescribed to teenage girls to treat mild acne, and to all women as a treatment for premenstrual disorders. It contains less estradiol compared to Yasmin. Yaz contains a different kind of hormone than other birth control pills. The hormone, drospirenone, can cause an increase in potassium which can lead to hyperkalemia. It has become clear that drospirenone can have uniquely dangerous side effects.
Gallbladder disease is one of the most common side effects from Yaz and Yasmin, both of which increase the amount of estrogen in the female body. This increase in estrogen level raises the bodies cholesterol level, increasing the risk of developing gallstones within the gallbladder, which is part of the liver. Painful attacks from gallstones are generally felt in the back or the abdomen, and can occur in rapid succession, lasting up to five hours. Gallstones can become a recurring injury, lasting a lifetime often requiring surgical removal of the gall bladder, itself.
Many women with no family history of blood clots or stroke problems have unfortunately experienced life-changing injuries including permanent loss of movement, difficulty communicating, and permanent loss of brain functions. Yaz has caused strokes where no other health problems exist. This condition is marked by unsafe levels of potassium that can disrupt normal heart rhythms and slow the flow of blood leading to potential clotting. Women with high blood potassium, women taking NSAIDs (aspirin, ibuprofen or naproxen) and/or women taking ACE inhibitors may be at higher risk for complications. Yaz induced blood clots can break forth from the wall of the vein and travel in the bloodstream toward the heart, lungs or brain. If they create an obstruction in any key blood vessel the clot can trigger a heart attack, pulmonary embolism and/or stroke.
In recent months, a number of lawsuits have been filed over Yaz and Yasmin. Hummer Law Offices is proud to represent clients who have suffered injuries as a result of these defective oral contraceptives, and other defective drugs and medical products.
Gianvi Overview Gianvi is a once-daily oral birth control pill. In 2010, the U.S. Food and Drug Administration (FDA) approved Gianvi to prevent pregnancy. It can also reduce mild acne and treat symptoms of premenstrual dysphoric disorder (PMDD). Gianvi is not approved to treat PMS or severe acne.
Gianvi is the generic form of Yaz. Both medications contain the same amount of active ingredients, the same risks, benefits, and side effects. The only major difference is that Yaz is sold by Bayer, and Gianvi is sold by a generic drug company called Teva Pharmaceuticals. Gianvi and Yaz are equally effective at preventing pregnancy, but Gianvi usually costs less than Yaz, which is why many women switched from Yaz to Gianvi when it was approved in 2010.
The Gianvi regimen consists of 24 active tablets, which each contain 3 mg of drospirenone (synthetic progestin) and 0.020 mg of ethinyl estradiol (synthetic estrogen). Four additional tablets are inactive, but help a woman stay in the habit of taking the pill at the same time every day.
When taken as directed, Gianvi is more than 99% effective at preventing pregnancy. It uses several mechanisms to decrease the chance that a woman will conceive. Gianvi inhibits the ovaries from releasing an egg (ovulation), and also changes the cervical mucus, which makes it difficult for sperm to enter the uterus. Gianvi also changes the endometrium, which makes it difficult for a fertilized egg to implant and grow.
Gianvi belongs to the “fourth generation” of oral contraceptives that contain drospirenone, a synthetic form of the female sex hormone progestin. Other contraceptives in this category include Yaz, Yasmin, Ocella, Beyaz, Zarah, Safyral, and Syeda.
What is the problem with Drospirenone? Gianvi, Yaz, and other “fourth generation” contraceptives contain drospirenone. Drospirenone is under intense scrutiny after several studies found significantly higher risk of side effects than older types of birth control.
All birth control pills increase a woman’s risk of blood clots. Birth control pills that have been on the market since the 1980s have been studied thoroughly, and the FDA has concluded that the risk of side effects is small.
However, five new studies have linked drospirenone to a significantly increased risk of blood clots, strokes, pulmonary embolisms, and death. These non-FDA studies have found similar results:
Now these two oral contraceptives are the subject of multiple lawsuits that allege they are responsible for several life-threatening complications to include blood clots, gallbladder disease, pulmonary embolism, heart attacks (myocardial infarction), sudden death, stroke, thromboembolism (deep vein thrombosis - DVT), high blood pressure, liver tumors, depression, edema and weight gain. This long list of potential injuries have caused many women to stop using the drug.
Due to its many alarming side effects, Yaz lawsuits are increasing across the US. To date, a total of 32 federal lawsuits have been filed throughout the country on behalf of Yaz victims. These lawsuits are based on claims of strict liability, negligence, and failure to warn.
VIDEO RESOURCE View videos related to this topic in our resource library.
Deep Vein Thrombosis (DVT)
Venous Thromboembolism (VTE)
Pulmonary Embolism (PE)
Abnormal heart rhythm
2009: Two studies published in the Canadian Medical Association Journal found that women may be twice as likely to develop a blood clot compared to women using other forms of birth control.
2011: Two studies published in the British Medical Journal, found women who took birth control with drospirenone were up to three times more likely to develop a blood clot.
November 2011: A massive Israeli study followed 329,995 women in Israel found the risk of blood clots may be more than 40% higher for drospirenone-containing contraceptives.
FDA Safety Warning for Drospirenone October 2011 - The FDA announced results of a preliminary study. After studying nearly 800,000 women using contraceptives with drospirenone, the FDA found women have at least a 75% increased chance of developing a blood clot compared with non-drospirenone contraceptives. The risk of developing blood clots is greatest for women in their first year of taking Gianvi or Yaz.
Gianvi Side Effects Gianvi has the same side effects as its brand-name equivalent, Yaz, and other fourth generation contraceptives. The most serious side effect is a stroke, which could cause death.
Strokes are caused by blood clots traveling through the blood stream and becoming stuck in the arteries that supply oxygenated blood to an organ. Serious injury or death can occur very quickly if a blood clot becomes lodged in the heart, lungs, brain, or other major internal organs.
Drospirenone increases the level of potassium in a woman’s blood stream, which can lead to the formation of blood clots in the large arteries in the extremities, usually the legs. This side effect is called Deep Vein Thrombosis (DVT). If you are taking birth control with drospirenone, you should consult your doctor so that you can recognize the symptoms of a blood clot. If you experience swelling, pain, numbness, a “tingling” sensation, slurred speech, or blurred vision, you should contact an emergency physician immediately, because these symptoms may be the precursors to a stroke.
Blood clots caused by DVT may occasionally break loose and travel through the bloodstream. This is called an embolism. A life-threatening side effect of using Gianvi is a Pulmonary embolism (PE), when an embolism travel becomes lodged in the artery leading to the lung. The resulting lack of oxygen can cause serious injury to the internal organs. If untreated, 30% of people who have a PE will die, usually within the first few hours of the event.
The risk of other side effects is increased for women who smoke, particularly women who are over 35 years old. These side effects may include cardiovascular events, liver disease, uterine bleeding, and gallbladder disease.
Side effects of Gianvi may include, but are not limited to: